Dexmedetomidine by Teikoku Pharma USA for Post-Operative Pain: Likelihood of Approval

Dexmedetomidine is under clinical development by Teikoku Pharma USA and currently in Phase II for Post-Operative Pain.

Jul 7, 2023 - 20:00
Dexmedetomidine is under clinical development by Teikoku Pharma USA and currently in Phase II for Post-Operative Pain.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow